what receptors does tirzepatide work on is a groundbreaking, once-weekly injectable medication that acts as a dual GIP and GLP-1 receptor agonist. Marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, it mimics Novel Dual Incretin Receptor Agonists
Pay in 4 interest-free payments of $6.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5






:max_bytes(150000):strip_icc()/VWH-Wegovy-receives-FDA-approval-for-treating-MASH-51d3bd1a89894b5e80b8a1a093d30a63.jpg)




















